Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study-Reference-Cited by-同舟云学术

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study

Published:2015-03-10 Issue:12 Volume:121 Page:1937-1948
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Vaz-Luis Ines¹,Hughes Melissa E.¹,Cronin Angel M.¹,Rugo Hope S.²,Edge Stephen B.³,Moy Beverly⁴,Theriault Richard L.⁵,Hassett Michael J.¹,Winer Eric P.¹,Lin Nancy U.¹

Affiliation:

1. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

2. Division of; Medical Oncology, Department of Medicine; University of California at San Francisco Helen Diller Family Comprehensive Cancer Center; San Francisco California

3. Department of Medical Oncology; Baptist Cancer Center; Memphis Tennessee

4. Department of Medical Oncology; Massachusetts General Hospital; Boston Massachusetts

5. Department of Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29310/fullpdf

Reference18 articles.

1. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies;Chia;J Clin Oncol,2004

2. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up;Rosen;J Clin Oncol,1993